Skip to main content
. 2019 Mar 7;9:3895. doi: 10.1038/s41598-019-40691-7

Table 2.

Bone mineral density change among patients with schizophrenia and healthy individuals.

Controls Non-clozapine antipsychotics Clozapine P value
DEXA Z score, overall (N = 44) (N = 69) (N = 42)
Baseline, mean (SD) 0.28 (1.09) −0.28 (1.14) 0.38 (1.45) 0.008
Endpoint, mean (SD) 0.42 (1.08) −0.44 (0.96) 0.41 (1.49) <0.001
Difference, mean (SD) 0.16 (0.47) −0.16 (0.66) 0.03 (0.64) 0.015
DEXA Z score, 1 year follow up (N = 48) (N = 29)
Baseline, mean (SD) −0.54 (1.10) 0.16 (1.49) 0.017
Endpoint, mean (SD) −0.68 (0.88) 0.09 (1.47) 0.006
Difference, mean (SD) −0.13 (0.56) −0.08 (0.70) 0.808
DEXA Z score, 3 year follow up (N = 44) (N = 22) (N = 13)
Baseline, mean (SD) 0.28 (1.09) 0.28 (1.15) 0.88 (1.29) 0.228
Endpoint, mean (SD) 0.42 (1.08) 0.09 (0.93) 1.13 (1.29) 0.052
Difference, mean (SD) 0.16 (0.47) −0.21 (0.87) 0.25 (0.41) 0.039

Mann-Whitney U test, for variables with non-normal distributions.